These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 11020282)

  • 1. Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.
    Scozzafava A; Supuran CT
    J Med Chem; 2000 Oct; 43(20):3677-87. PubMed ID: 11020282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative QSAR study on carbonic anhydrase and matrix metalloproteinase inhibition by sulfonylated amino acid hydroxamates.
    Gupta SP; Maheswaran V; Pande V; Kumar D
    J Enzyme Inhib Med Chem; 2003 Feb; 18(1):7-13. PubMed ID: 12751815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-Substituted-(1,2,3-triazol-4-yl)thiophene-2-sulfonamides strongly inhibit human carbonic anhydrases I, II, IX and XII: solution and X-ray crystallographic studies.
    Leitans J; Sprudza A; Tanc M; Vozny I; Zalubovskis R; Tars K; Supuran CT
    Bioorg Med Chem; 2013 Sep; 21(17):5130-8. PubMed ID: 23859774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbonic anhydrase inhibitors: inhibition of cytosolic/tumor-associated isoforms I, II, and IX with iminodiacetic carboxylates/hydroxamates also incorporating benzenesulfonamide moieties.
    Santos MA; Marques S; Vullo D; Innocenti A; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1538-43. PubMed ID: 17251018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbonic anhydrase and matrix metalloproteinase inhibitors. Inhibition of human tumor-associated isozymes IX and cytosolic isozyme I and II with sulfonylated hydroxamates.
    Nuti E; Orlandini E; Nencetti S; Rossello A; Innocenti A; Scozzafava A; Supuran CT
    Bioorg Med Chem; 2007 Mar; 15(6):2298-311. PubMed ID: 17276072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbonic anhydrase inhibitors: synthesis and inhibition of the human cytosolic isozymes I and II and transmembrane isozymes IX, XII (cancer-associated) and XIV with 4-substituted 3-pyridinesulfonamides.
    Brzozowski Z; Sławiński J; Saczewski F; Innocenti A; Supuran CT
    Eur J Med Chem; 2010 Jun; 45(6):2396-404. PubMed ID: 20202722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with N-hydroxysulfamides--a new zinc-binding function in the design of inhibitors.
    Winum JY; Innocenti A; Nasr J; Montero JL; Scozzafava A; Vullo D; Supuran CT
    Bioorg Med Chem Lett; 2005 May; 15(9):2353-8. PubMed ID: 15837324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of a new series of N⁴-substituted 4-(2-aminoethyl)benzenesulfonamides and their inhibitory effect on human carbonic anhydrase cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII.
    Sławiński J; Brzozowski Z; Żołnowska B; Szafrański K; Pogorzelska A; Vullo D; Supuran CT
    Eur J Med Chem; 2014 Sep; 84():59-67. PubMed ID: 25016228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protease inhibitors. Part 8: synthesis of potent Clostridium histolyticum collagenase inhibitors incorporating sulfonylated L-alanine hydroxamate moieties.
    Scozzafava A; Supuran CT
    Bioorg Med Chem; 2000 Mar; 8(3):637-45. PubMed ID: 10732980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbonic anhydrase inhibitors: sulfonamides as antitumor agents?
    Supuran CT; Briganti F; Tilli S; Chegwidden WR; Scozzafava A
    Bioorg Med Chem; 2001 Mar; 9(3):703-14. PubMed ID: 11310605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbonic anhydrase inhibitors. Inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with Schiff's bases incorporating chromone and aromatic sulfonamide moieties, and their zinc complexes.
    Puccetti L; Fasolis G; Vullo D; Chohan ZH; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3096-101. PubMed ID: 15908204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbonic anhydrase inhibitors. Synthesis of heterocyclic 4-substituted pyridine-3-sulfonamide derivatives and their inhibition of the human cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII.
    Sławiński J; Szafrański K; Vullo D; Supuran CT
    Eur J Med Chem; 2013 Nov; 69():701-10. PubMed ID: 24095761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protease inhibitors. Part 12. Synthesis of potent matrix metalloproteinase and bacterial collagenase inhibitors incorporating sulfonylated N-4-nitrobenzyl-beta-alanine hydroxamate moieties.
    Scozzafava A; Ilies MA; Manole G; Supuran CT
    Eur J Pharm Sci; 2000 Jul; 11(1):69-79. PubMed ID: 10913755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxyurea is a carbonic anhydrase inhibitor.
    Scozzafava A; Supuran CT
    Bioorg Med Chem; 2003 May; 11(10):2241-6. PubMed ID: 12713833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New hydroxypyrimidinone-containing sulfonamides as carbonic anhydrase inhibitors also acting as MMP inhibitors.
    Esteves MA; Ortet O; Capelo A; Supuran CT; Marques SM; Santos MA
    Bioorg Med Chem Lett; 2010 Jun; 20(12):3623-7. PubMed ID: 20478708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbonic anhydrase inhibitors. Synthesis, and molecular structure of novel series N-substituted N'-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII.
    Żołnowska B; Sławiński J; Pogorzelska A; Chojnacki J; Vullo D; Supuran CT
    Eur J Med Chem; 2014 Jan; 71():135-47. PubMed ID: 24291567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human carbonic anhydrase isozymes I, II, IX and XII with a new series of sulfonamides incorporating aroylhydrazone-, [1,2,4]triazolo[3,4-b][1,3,4]thiadiazinyl- or 2-(cyanophenylmethylene)-1,3,4-thiadiazol-3(2H)-yl moieties.
    Alafeefy AM; Abdel-Aziz HA; Vullo D; Al-Tamimi AM; Awaad AS; Mohamed MA; Capasso C; Supuran CT
    J Enzyme Inhib Med Chem; 2015 Feb; 30(1):52-6. PubMed ID: 24666294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbonic anhydrase inhibitors. Synthesis of a novel series of 5-substituted 2,4-dichlorobenzenesulfonamides and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII.
    Sławiński J; Pogorzelska A; Żołnowska B; Brożewicz K; Vullo D; Supuran CT
    Eur J Med Chem; 2014 Jul; 82():47-55. PubMed ID: 24871996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel sulfonamides incorporating 1,3,5-triazine and amino acid structural motifs as inhibitors of the physiological carbonic anhydrase isozymes I, II and IV and tumor-associated isozyme IX.
    Mikuš P; Krajčiová D; Mikulová M; Horváth B; Pecher D; Garaj V; Bua S; Angeli A; Supuran CT
    Bioorg Chem; 2018 Dec; 81():241-252. PubMed ID: 30153589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New series of sulfonamides containing amino acid moiety act as effective and selective inhibitors of tumor-associated carbonic anhydrase XII.
    Ceruso M; Bragagni M; AlOthman Z; Osman SM; Supuran CT
    J Enzyme Inhib Med Chem; 2015 Jun; 30(3):430-4. PubMed ID: 25089707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.